Skip to main content

Table 2 Comparison of patients treated with Add-rLH or Non-Add-rLH IVF down-regulation regimens

From: Analysis of androgen receptor and anti-Müllerian hormone pathways in human granulosa cells under luteinizing hormone treatment

Transfer

Add-rLH cycles

Non-Add-rLH cycles

P

No. patients

35

70

 

Age of female partners (yrs)

33.4 +/- 4.1

33.2 +/- 4.2

ns

Body mass index

21.5 +/- 3.1

21.6 +/- 3.1

ns

Infertility

   

Primary (%)

68.6 (24/35)

55.7 (39/70)

ns

Secondary (%)

31.4 (11/35)

44.3 (31/70)

ns

Reason for infertility (No. of patients)

   

Tubal factor

11

23

ns

Male factor

17

32

ns

Unexplained

3

2

ns

Combined factor

4

13

ns

Duration of infertility (years)

4.0 +/- 2.4

4.0 +/- 3.0

ns

Days of FSH treatment

8.6 +/- 1.8

9.1 +/- 1.7

ns

FSH (IU)

2062.5 +/- 975.0

2385.0 +/- 855.0

ns

LH (IU)

3525.0 +/- 225.0

  

Endometrial thickness on day of hCG stimulation (cm)

1.4 +/- 0.3

1.3 +/- 0.3

ns

LH (mIU/mL) on day of hCG stimulation

2.6 +/- 1.6

1.9 +/- 1.2

0.021

Estradiol (pg/mL) on day of hCG stimulation

1681.9 +/- 1021.7

1851.8 +/- 1166.2

ns

Progesterone (ng/mL) on day of hCG stimulation

1.2 +/- 0.4

1.1 +/- 0.4

ns

No. mature & near-mature oocytes retrieved

5.9 +/- 4.2

6.5 +/- 3.3

ns

No. mature oocytes retrieved

3.7 +/- 2.7

3.9 +/- 2.1

ns

Normal fertilization rate

77.8 +/- 33.1%

79.4 +/- 23.3%

ns

Mean No. embryos transferred

2.1 +/- 0.6

2.3 +/- 0.6

ns

Clinical pregnancy rate per transfer

34.2% (12/35)

32.8% (23/70)

ns

  1. Note: Values are mean ± SD or proportion.